Delivery Order SPE2DB20D7066-SPE2DB25FC1XF

Award Date 12/17/24
Potential Completion Date 12/18/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC1XF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,162.38 Firm Fixed Price Delivery Order is for the supply of 4566736884 - ROPIVACAINE 0.2% 200 MG/100 ML 100ML, a pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition. As a major vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen plays a critical role in supplying medical products to various government agencies.

Generated 3/18/25, 9:59 AM